AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11753789
Drug: Oxaliplatin (l-OHP)
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin (l-OHP)
Trial: 9028308
Drug: G‐CSF (granulocyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF (granulocyte colony‐stimulating factor) at a dosage of 5 micrograms/kg, starting the day after completion of the third cycle of chemotherapy.
Trial: 6752872
Drug: Pirprofen 600
RxNorm normalized name: Carprofen
DrugBank: Carprofen (DB00821)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pirprofen 600 mg/day
Trial: 6752875
Drug: Ketoprofen 300
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen 300 mg/day
Trial: 20180611
Drug: No Proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Proton Pump Inhibitors (PPIs)
Trial: 1337337
Drug: GM-CSF administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GM-CSF administration starting one day after chemotherapy for 7-10 days
Trial: 1337337
Drug: GM-CSF administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GM-CSF administration after high-dose chemotherapy
Trial: 1337337
Drug: GM-CSF administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GM-CSF administration after initial cycles of chemotherapy
Trial: 27139019
Drug: No ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ice pack therapy (Control Group B).
Trial: 20431422
Drug: CRAI (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRAI (continuous regional arterial infusion) with nafamostat mesylate 240 mg/d and imipenem 1 g/d for 5 days, followed by imipenem intravenously (0.5 g every 8 hours) for 9 days
Trial: 19089223
Drug: Orthodontic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic treatment in Class II/1 malocclusion patients (group T)
Trial: 11808967
Drug: COX-2-specific inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: COX-2-specific inhibitor and traditional NSAID therapy
Trial: 2823841
Drug: 5000 IU
RxNorm normalized name: D 5000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 IU unfractionated heparin
Trial: 7853952
Drug: 2000 anti-Xa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 anti-Xa IU low-molecular-weight heparin
Trial: 29431028
Drug: Kindergartens where
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kindergartens where parents paid a monthly fee of 251 NOK or more
Trial: 29431028
Drug: Kindergartens where
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kindergartens where employees paid a monthly fee to eat at work
Trial: 29420395
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ulipristal acetate
Trial: 29420395
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ulipristal acetate
Trial: 14870949
Drug: Alcohol 0.5
RxNorm normalized name: isopropyl alcohol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.5 g/kg
Trial: 1791932
Drug: Alcohol 0.3
RxNorm normalized name: ALCOHOL 0.3 TOPICAL CLOTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.3 g/kg
Trial: 9834924
Drug: Enteral formula
RxNorm normalized name: Standard enteral formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral formula enriched with arginine, omega‐3 fatty acids, and RNA administered 7 days before and 7 days after surgery
Trial: 18383334
Drug: Methacholine challenge
RxNorm normalized name: Methacholine Challenge Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine challenge (PC20 < or = 4.0 mg/ml) in girls
Trial: 18383334
Drug: Methacholine challenge
RxNorm normalized name: Methacholine Challenge Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine challenge (PC20 < or = 8.0 mg/ml) in nonatopic girls
Trial: 18383334
Drug: Methacholine challenge
RxNorm normalized name: Methacholine Challenge Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine challenge (PC20 < or = 2.0 mg/ml) in atopic boys
Trial: 12370838
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (glipizide GITS + metformin)
Trial: 2147787
Drug: Saliva stimulants
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saliva stimulants (Salivin lozenge)
Trial: 29715369
Drug: PEG/PG QID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG/PG QID (four times daily)
Trial: 15670536
Drug: Ranolazine 400
RxNorm normalized name: Ranolazine
DrugBank: Ranolazine (DB00243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranolazine 400 mg three times daily
Trial: 31277446
Drug: Mediterranean diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mediterranean diet with 2-3 weekly servings of fresh, lean pork (MedPork)
Trial: 22415333
Drug: Famotidine treatment
RxNorm normalized name: Famotidine
DrugBank: Famotidine (DB00927)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Famotidine treatment
Trial: 11835120
Drug: Technosphere/Insulin (TI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Technosphere/Insulin (TI) via inhalation
Trial: 10049414
Drug: Ciprofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500 mg twice daily) and Rowachol (2 tablets 3 times daily)
Trial: 7586262
Drug: Steroid-eluting lead
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-eluting lead (Medtronic model 4068)
Trial: 2338106
Drug: Chemotherapy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy without any antiemetic treatment
Trial: 111546
Drug: Lactinex (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactinex (Lactobacillus acidophilus and L bulgaricus), 1 packet four times daily for the first five days of ampicillin therapy
Trial: 24131736
Drug: PF-04360365 (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-04360365 (0.1, 0.5, 1, 5, or 10 mg/kg)
Trial: 17890232
Drug: Prandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prandial insulin aspart three times daily
Trial: 17890232
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin detemir once daily (twice if required)
Trial: 18020110
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
Trial: 18020110
Drug: N-methyl-D-aspartate receptor
RxNorm normalized name: N-methyl-D-aspartate receptor antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-methyl-D-aspartate receptor antagonist (memantine)
Trial: 9892909
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment (50 microg/g)
Trial: 9892909
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate (64 mg/g) and salicylic acid (0.03 g/g) ointment
Trial: 8070028
Drug: Etoposide phosphate
RxNorm normalized name: Etoposide Phosphate
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide phosphate (EP) given at maximum tolerated doses of 100 mg/m2 (daily for 5 days) and 150 mg/m2 (on days 1, 3, and 5)
Trial: 30020092
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of daily living practiced using real materials
Trial: 18559367
Drug: Amoxicillin (HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (HIV infected)
Trial: 18559367
Drug: Amoxicillin (HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (HIV uninfected)
Trial: 10844161
Drug: Pycnogenol (French
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol (French maritime pine bark extract), 100 mg x 3/day
Trial: 9070128
Drug: Cytotoxic drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic drug delivery system using 5-fluorouracil applied directly to the cervix.
Trial: 2878839
Drug: Triacetin-prostaglandin E2-gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triacetin-prostaglandin E2-gel
Trial: 29140138
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg b.i.d.)
Trial: 17638034
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment plus routine care
Trial: 16842664
Drug: Magnetocardiography (MCG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetocardiography (MCG) in CAD group
Trial: 11027812
Drug: Formalin-inactivated JE
RxNorm normalized name: formalin
DrugBank: Formaldehyde (DB03843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Formalin-inactivated JE and placebo vaccines
Trial: 25976090
Drug: Healing Touch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healing Touch (noninvasive energy therapy) for 15 minutes prior to biopsy procedure
Trial: 25124490
Drug: Oligonol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligonol 200 mg
Trial: 19079142
Drug: 360 degree
RxNorm normalized name: NEEDLE 20G 1IN BENT 90 DEGREES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 degree anterior capsule polishing (group 1)
Trial: 19079142
Drug: No anterior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anterior capsule polishing (group 2, controls)
Trial: 15893381
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulphate (MgSO(4)) administered at 150-200 mg/h for 24 hours (n=22)
Trial: 15893381
Drug: NaCl 0.9%
RxNorm normalized name: DEXTROSE 5%/NACL 0.9% INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl 0.9% administered intravenously (n=19)
Trial: 6349719
Drug: Androgen alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen alone (concurrent STANDARD care controls)
Trial: 22236345
Drug: 5.0 mg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg/ml bupivacaine infusion at 2 ml/h for 48 hours
Trial: 10716466
Drug: Gemfibrozil (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (1,200 mg/day)
Trial: 12384411
Drug: Idarubicin (IDA)
DrugBank: Idarubicin (DB01177)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Idarubicin (IDA) alone, 10 mg/m² daily for 6 days
Trial: 7753585
Drug: Albendazole treatment
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole treatment in undernourished children (Z-score < -1)
Trial: 19104723
Drug: Spironolactone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (25 mg/day) with ACE inhibitor
Trial: 19716598
Drug: Tiotropium (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (18 microg once daily)
Trial: 18209516
Drug: Mirtazapine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (30 mg)
Trial: 10325901
Drug: Pulsed dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed dose oxygen delivery (PDOD) system
Trial: 10325901
Drug: Continuous flow
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous flow oxygen at 2 l/min
Trial: 6352272
Drug: penbutolol 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: penbutolol 40 mg
Trial: 29798059
Drug: Flunarizine 10
RxNorm normalized name: flunarizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine 10 mg daily for 3 months along with betahistine 12 mg Tid for 48 h during episodes
Trial: 24830937
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution (30 mL)
Trial: 12229133
Drug: 1 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg.kg‐1 flurbiprofen i.v. at the end of surgery
Trial: 12229133
Drug: 1 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg.kg‐1 flurbiprofen i.v. before the start of surgery
Trial: 9454160
Drug: Conventional irradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional irradiation (once a day, 2.2 Gy to a total dose of 70 Gy to 77 Gy)
Trial: 2108575
Drug: tissue plasminogen
RxNorm normalized name: Tissue plasminogen activator
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tissue plasminogen activator (t-PA) 100 to 150 mg intravenously over 6 to 8 hours
Trial: 375849
Drug: Diflunisal (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflunisal (750 mg per day)
Trial: 29493562
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (systolic blood pressure target of less than 120 mmHg)
Trial: 25112584
Drug: naloxegol 25
RxNorm normalized name: naloxegol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naloxegol 25 mg/day
Trial: 25112584
Drug: usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: usual care (UC; investigator-chosen laxative regimen)
Trial: 16182025
Drug: Follow-up without
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up without therapy (Control)
Trial: 16182025
Drug: Bone setting
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone setting (5 weekly sessions)
Trial: 29772111
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 50 mg
Trial: 8775936
Drug: Angiotensin-converting-enzyme inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting-enzyme inhibitors
Trial: 2776469
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg flurbiprofen twice daily
Trial: 3508329
Drug: 375 mg
RxNorm normalized name: niacin 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 mg naproxen twice daily
Trial: 7128668
Drug: Amezinium 30
RxNorm normalized name: amezinium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amezinium 30 mg
Trial: 28949089
Drug: Placebo (wrapped
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (wrapped isovolumetric saline infusion)
Trial: 28949089
Drug: IVIG (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (4 doses of 0.5 g/kg) and RTX (375 mg/m2)
Trial: 27788771
Drug: Preparation with
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation with continuous irrigation
Trial: 24411144
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (weekly one hour sessions for eight weeks)
Trial: 20609468
Drug: Olaparib 400
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Olaparib 400 mg twice daily
Trial: 29258133
Drug: Daily constancy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily constancy test
Trial: 10445416
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg per day for 10 days)
Trial: 10445416
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment (diet, corsil)
Trial: 7598769
Drug: Plasma-derived HB
RxNorm normalized name: Haptoglobulin 1/1 (Plasma Derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma-derived HB vaccine with yellow fever vaccine
Trial: 7598769
Drug: Recombinant HB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant HB vaccine with yellow fever vaccine
Trial: 7598769
Drug: Polio vaccine
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polio vaccine with plasma-derived HB vaccine
Trial: 7598769
Drug: Polio vaccine
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polio vaccine with recombinant HB vaccine
Trial: 2262356
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C - 60Co 60 Gy in 30 fractions plus chemotherapy (5 Fu, 250 mg/m2/IV every 2 days)
Trial: 902232
Drug: Methanol extraction
RxNorm normalized name: methanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methanol extraction residue (MER) of Bacille‐Calmette‐Guerin (BCG) in addition to radiotherapy and/or chemotherapy
Trial: 902232
Drug: Radiotherapy and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy and/or chemotherapy alone
Trial: 25826870
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (5% solution, 20 ml/day for 20 days)
Trial: 25826870
Drug: Cytoflavin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavin (10 ml intravenously, twice a day for 10 days)
Trial: 25826870
Drug: Cytoflavin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavin (20 ml/day for first 10 days, 10 ml/day for next 10 days)
Trial: 16405547
Drug: >=2 contrast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: >=2 contrast injections into the pancreatic duct
Trial: 7604809
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg daily)
Trial: 8993943
Drug: Ciprofibrate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofibrate (100 mg daily)
Trial: 10734016
Drug: 4 microgram/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 microgram/kg IL-10 subcutaneously daily for 90 days
Trial: 10734016
Drug: 8 microgram/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 microgram/kg IL-10 subcutaneously daily for 90 days
Trial: 8736999
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of opioid receptor density in C57BL/6 mice and DBA/2 mice
Trial: 8736999
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of opioid receptor density in AA rats and ANA rats
Trial: 1551151
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous (PCA-i.v.) fentanyl
Trial: 3926511
Drug: Glucose infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose infusions
Trial: 12462350
Drug: Saline infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusions
Trial: 25740265
Drug: QMF149 150/320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QMF149 150/320 μg
Trial: 10345150
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba (EGb 761) 80 mg twice daily
Trial: 10345150
Drug: Betahistine dihydrochloride
RxNorm normalized name: Betahistine Dihydrochloride
DrugBank: Betahistine (DB06698)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betahistine dihydrochloride (BI) 16 mg twice daily
Trial: 25311914
Drug: GnRH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH treatment (100 µg)
Trial: 28799258
Drug: Helicobacter pylori
RxNorm normalized name: HELICOBACTER PYLORI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helicobacter pylori eradication treatment
Trial: 16925613
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori treatment
Trial: 11253839
Drug: High-dose zidovudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose zidovudine (AZT) 1500 mg/day
Trial: 28407338
Drug: Tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine ER 4 mg once daily for 12 weeks
Trial: 23377513
Drug: Combination gel
RxNorm normalized name: SUNSCREEN-30 PABA-FREE COMBINATION GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination gel (clindamycin phosphate 1.2% and tretinoin 0.025%)
Trial: 20650919
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.75 mg kg(‐1) bolus then infusion 1 mg kg(‐1) h(‐1))
Trial: 20650919
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (1.5 mg kg(‐1) bolus and infusion 2 mg kg(‐1) h(‐1))
Trial: 20650919
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (3 mg kg(‐1) bolus and infusion 4 mg kg(‐1) h(‐1))
Trial: 18772216
Drug: i.v. midazolam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. midazolam 0.02 mg kg(‐1)
Trial: 12088299
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of surgery and radiation therapy
Trial: 12088299
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant therapy based on pathologic risk factors